A DOUBLE-MASKED PLACEBO-CONTROLLED, EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE IN THE TREATMENT OF CONTACT-LENS ASSOCIATED GIANT PAPILLARY CONJUNCTIVITIS

被引：0
|
作者：
HOWES, JF [1 ]
ASBELL, PA [1 ]
机构：
[1] CUNY MT SINAI SCH MED,NEW YORK,NY 10029
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 1995年 / 36卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：S630 / S630
页数：1
相关论文
共 50 条
  • [1] A double-masked, placebo-controlled evaluation of the efficacy and safety of loteprednol etabonate in the treatment of giant papillary conjunctivitis
    Friedlaender, MH
    Howes, J
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (04) : 455 - 464
  • [2] A DOUBLE-MASKED, PLACEBO-CONTROLLED EVALUATION OF THE EFFICACY AND SAFETY OF LOTEPREDNOL ETABONATE (LE) IN THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS (SAC)
    DELL, SJ
    SHULMAN, DG
    LOWRY, GM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S862 - S862
  • [3] SAFETY AND EFFICACY OF LOTEPREDNOL ETABONATE FOR TREATMENT OF PAPILLAE IN CONTACT LENS-ASSOCIATED GIANT PAPILLARY CONJUNCTIVITIS
    BARTLETT, JD
    HOWES, JF
    GHORMLEY, NR
    AMOS, JF
    LAIBOVITZ, R
    HORWITZ, B
    CURRENT EYE RESEARCH, 1993, 12 (04) : 313 - 321
  • [4] A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation
    Beehler, C
    Bodner, B
    Bowman, B
    Cooke, D
    Crabb, JL
    DeBarge, LR
    Donnenfeld, E
    Estopinal, M
    Fox, K
    Kastl, P
    Olander, K
    Sharpe, E
    Shofner, R
    Stahl, J
    Stevenson, D
    Stewart, W
    Walters, T
    Gill, S
    Howes, J
    Lawson, C
    Smerick, M
    Zaccardelli, D
    Fazio, R
    Novack, GD
    Crockett, RS
    Hart, K
    OPHTHALMOLOGY, 1998, 105 (09) : 1780 - 1786
  • [5] Double-masked, placebo-controlled evaluation of loteprednol etabonate 0.5% for postoperative inflammation
    Stewart, R
    Horwitz, B
    Howes, J
    Novack, GD
    Hart, K
    JOURNAL OF CATARACT AND REFRACTIVE SURGERY, 1998, 24 (11): : 1480 - 1489
  • [6] SAFETY AND EFFICACY OF LOTEPREDNOL ETABONATE FOR TREATMENT OF GIANT PAPILLARY CONJUNCTIVITIS
    HOWES, JF
    BARTLETT, JD
    GHORMLEY, NR
    AMOS, JF
    LAIBOVITZ, R
    HORWITZ, B
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1992, 33 (04) : 1294 - 1294
  • [7] A randomized, double-masked, placebo-controlled parallel study of 0.2% loteprednol etabonate in patients with seasonal allergic conjunctivitis
    Dell, SJ
    Lowry, GM
    Northcutt, JA
    Howes, J
    Novack, GD
    Hart, K
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1998, 102 (02) : 251 - 255
  • [8] A randomized, double masked, placebo-controlled parallel study of loteprednol etabonate 0.2% in patients with seasonal allergic conjunctivitis
    Shulman, DG
    Lothringer, LL
    Rubin, JM
    Briggs, RB
    Howes, J
    Novack, GD
    Hart, K
    OPHTHALMOLOGY, 1999, 106 (02) : 362 - 369
  • [9] A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis
    Dell, SJ
    Shulman, DG
    Lowry, GM
    Howes, J
    Berdy, G
    Embry, S
    Fox, K
    Horwitz, B
    KuneshPart, K
    Laibovitz, R
    Levin, J
    Lowry, G
    Orlando, R
    Parks, D
    Walters, T
    Coultas, S
    Hart, K
    Crockett, RS
    Novack, GD
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (06) : 791 - 797
  • [10] HISTOLOGY OF HARD AND SOFT CONTACT-LENS ASSOCIATED GIANT PAPILLARY CONJUNCTIVITIS
    HENRIQUEZ, AS
    BAIRD, RS
    KORB, DR
    ALLANSMITH, MR
    ANNALS OF OPHTHALMOLOGY, 1980, 12 (08): : 929 - 933
12345